Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to β cells of the pancreas to stimulate insulin release. Nateglinide is an amino acid derivative that induces an early insulin response to mea...
For the treatment of non-insulin dependent-diabetes mellitus in conjunction with diet and exercise.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.